Clinical significance of interferon γ release assay for diagnosis of tuberculosis in children

Korean Journal of Pediatric Infectious Diseases

Volumn 17, Issue 2, 2010, Pages 137-147

  Lee, Hee Woo ^a   Park, Hwa Young ^a   Ahn, Young Min ^a   Sohn, Keun Chan ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

Children; Interferon release assay; QuantiFERON TB Gold assay; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GAMMA INTERFERON RELEASE ASSAY; HUMAN; IMMUNE FUNCTION TEST; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84862566388     PISSN: 12263923     EISSN: None     Source Type: Journal    
DOI: 10.14776/kjpid.2010.17.2.137     Document Type: Article

References (39)

1. World Health Organization. Global tuberculosis control: surveilance, planning, financing. Geneva, Switzerland: World Health Organization, 2002.
2. Shim TS, Koh WJ, Yim JJ, WJ. L. Diagnosis and treatment of latent tuberculosis infection in Korea. Tuberc Respir Dis 2004;282:677-86.
3. Shin KC. Report on the seventh national tuberculosis prevalence survey. The Korean Academy of Tuberculosis and Respiratory diseases 1997;85:171-7.
4. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-90.
5. Huebner RE, Schein MF, Bass JB, Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
6. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009; 123:30-7.
7. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
8. Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007; 175(3):282-7.
9. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367:1328-34.
10. Goletti D, Vincenti D, Carrara S, Butera O, Bizzoni F, Bernardini G, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005;12:1311-6.
11. Okada K, Mao TE, Mori T, Miura T, Sugiyama T, Yoshiyama T, et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 2008;136:1179-87.
12. Nakaoka H, Lawson L, Squire SB, Coulter B, Ravn P, Brock I, et al. Risk for tuberculosis among children. Emerg Infect Dis 2006;12:1383-8.
13. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-203.
14. Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009;28:669-73.
15. Lewinsohn DA. Embracing interferon-gamma release assays for diagnosis of latent tuberculosis infection. Pediatr Infect Dis J 2009;28:674-5.
16. Powell DA. Interferon gamma release assays in the evaluation of children with possible Mycobacterium tuberculosis infection: a view to caution. Pediatr Infect Dis J 2009;28:676-7.
17. Mazurek GH, Jereb J, Vernon A, Lobue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. CDC Morbidity and Mortality weekly report 2010;59:1-24.
18. Sung JY, Kim JH, Yang MA, Kim SH, Eun BW, Kim NH, et al. Usefulness of interferon gamma measurement following stimulation of tuberculosis-specific antigens for diagnosis of latent tuberculosis infection in children exposed to pulmonary tuberculosis. Korean J Pediatr Infect Dis 2008;15:51-7.
19. Chun JK, Kim CK, Kim HS, Jung GY, Linton JA, Kim KH, et al. Comparison of a whole blood Interferon gamma assay and A tuberculin skin test for detecting latent tuberculosis infection in children. Korean J Pediatr 2008;51:971-6.
20. Kim YJ, Lee JS. Comparison of Interferon gamma assays with the tuberculin skin test in children. Pediatr Allergy Respir Dis (Korea) 2010;20:10-6.
21. Han YM, Kim HS, Kim CH, Kang HJ, Lee KM. Analysis of patients with positive acid-fast bacilli culture and negative T-SPOT.TB results. Korean J Lab Med 2010; 30:414-9.
22. Kim BS, Hwang MH, Kim CH, Park JO, Shin SM. The effect of percutaneous multiple puncture BCG vaccination on PPD 1TU, 2TU and 5TU tuberculin skin test. Korean J Pediatr Infect Dis 2001;8:175-80.
23. Kim WS, Kim CH, Lee DH, Shin SM. Conversion rates of tuberculin test according to BCG vaccination methods. J Korean Pediatr 1997;40:489-96.
24. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204.
25. American Academy of Pediatrics, Committee on Infectious Diseases. Red book. report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village: American Academy of Pediatrics, 2003:642-60.
26. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006;61:616-20.
27. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM. Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol 2007;14:796-8.
28. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007;14:880-5.
29. Grare M, Derelle J, Dailloux M, Laurain C. Difficulties of TB diagnosis in children: QuantiFERON TB Gold[R] In-Tube as useful tool. Arch Pediatr 2010;17:77-85.
30. Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, Azzari C, et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009;28:510-4.
31. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009;33:812-5.
32. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the Quanti-FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15):49-55.
33. Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005;172:631-5.
34. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007;175:737-42.
35. Frenkel L, Bryson YJ. Ontogeny of phytohemagglutinininduced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr 1987; 111:97-100.
36. Miyawaki T, Seki H, Taga K, Sato H, Taniguchi N. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol 1985; 59:505-11.
37. Bosshard V, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T, et al. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? Respir Med 2009;103:30-4.
38. Dheda K, Pooran A, Pai M, Miller RF, Lesley K, Booth HL, et al. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 2007; 55:169-73.
39. Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, et al. Long-term follow-up of the Quanti FERON TB-2G test for active tuberculosis disease. Intern Med 2008;47:1957-61.